New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 10, 2014
16:28 EDTEBAY, FB, AGN, VRX, COUP, EHTH, INO, RCPTOn The Fly: Closing Wrap
Stocks on Wall Street began the day slightly below the flat line and remained there for most of the session, before a late move higher allowed the Dow to run its recent winning streak to another day, though just barely. Economic reports from at home and abroad, which included wholesale trade data in the U.S. and inflation data from China, had little effect on the market, which seemed content to spend the session drifting. The Dow and S&P 500 stand just short of major round-number milestones, but both will have to wait at least another day to see if they can be reached. ECONOMIC EVENTS: In the U.S., wholesale inventories rose 1.1% in April, with sales up 1.3%, which were both better than forecast. The JOLTS report showed job openings climbed 289K to 4.46M in April. In China, official data showed an index of consumer prices rose 2.5% year-on-year in May, while China's producer price index contracted 1.4% during the month. COMPANY NEWS: Shares of eBay (EBAY) closed down $1.33, or 2.68%, to $48.25 after the company announced last night that PayPal President David Marcus is leaving the company to lead Facebook’s (FB) messaging products. Facebook shares reacted positively to the executive hiring, rising $2.89, or 4.6%, to $65.77... Allergan (AGN) once again rejected Valeant (VRX), saying that the higher takeover bid it made in concert with Bill Ackman's hedge fund Pershing Square still "substantially undervalues the company [and] creates significant risks and uncertainties for the stockholders of Allergan." Further, Allergan said its board has "serious concerns" about the large stock component of the proposal and that the latest Valeant offer does not warrant talks between the companies. Following the latest reproach, BMO Capital said it believes the fight between the two is still in the "early innings" and could last well into 2015. Shares of Allergan slipped $1.06, or 0.65%, to $163.09, while Valeant fell $1.08, or 0.85%, to $125.55. MAJOR MOVERS: Among the notable gainers was hepatitis C treatment maker Achillion (ACHN), which surged $3.54, or 83.29%, to $7.79 after the company announced today that it had received favorable news from the FDA about resuming certain clinical trials. Achillion's advance comes on top of its 47% move higher yesterday after Merck (MRK) announced that it would acquire another company in the HCV drug space at a significant premium. Also higher was Receptos (RCPT), which jumped $10.74, or 36.78%, to $39.94 after the company reported phase 2 data for its SIPI modulator that firms Leerink and BMO Capital both viewed positively. Among the noteworthy losers was Inovio Pharmaceuticals (INO), which fell $1.44, or 13.36%, to $9.34 after TheStreet's Adam Feuerstein speculated that the company already has data in hand for its phase II study of its vaccine for cervical pre-cancerous lesions and warned of "red flags" related to the company's CEO "walking back expectations" ahead of a potential disclosure that the trial was not a success. Also lower were shares of eHealth (EHTH), which fell $5.09, or 13.05%, to $33.91 after Jefferies downgraded the stock to Hold and lowered its price target for shares to $40 from $62, citing less confidence in the company's Exchange opportunity following management comments at the firm's conference. Another stock moving lower following a downgrade was Coupons.com (COUP), which dropped $2.95, or 10.6%, to $24.88 after Goldman downgraded the shares to Sell from Neutral. INDEXES: The Dow was up 2.82, or 0.02%, to 16,945.92, the Nasdaq was up 1.75, or 0.04%, to 4,338.00, and the S&P 500 was down 0.48, or 0.02%, to 1,950.79.
News For EBAY;FB;AGN;VRX;COUP;EHTH;INO;RCPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
September 23, 2014
06:56 EDTFBGoogle exec to manage Snapchat PR, policy, Re/code says
Subscribe for More Information
06:28 EDTAGNTreasury rules may put Mylan deal at risk, says BMO Capital
BMO Capital believes Treasury's new inversion rules may put the tax benefits of Mylan's (MYL) planned acquisition of Abbott's (ABT) established products business at risk. BMO also thinks the rules impact Salix's (SLXP) pending deal for Cosmo Pharmaceuticals, which it feels may help make a deal with Allergan (AGN) more likely.
06:00 EDTFBFacebook expected to launch new advertising platform, WSJ reports
This week, Facebook (FB) will introduce Atlas, a new advertising platform to improve effectiveness of online ads, the Wall Street Journal reports, citing people familiar with the matter. Atlas is a re-engineered version of the Atlas Advertiser Suite Facebook acquired in 2013 from Microsoft (MSFT). Facebook is looking to challenge Google (GOOG) in the online ad space. Reference Link
05:56 EDTAGN, VRXTreasury, IRS announce plans to reduce inversion tax benefits
Subscribe for More Information
September 22, 2014
19:03 EDTAGN, VRXAllergan rejected buyout bid from Actavis, in advanced talks for Salix, WSJ says
Subscribe for More Information
08:10 EDTINOInovio initiates phase I clinical trial in patients with aerodigestive cancers
Inovio announced it has initiated a phase I clinical trial in patients with aerodigestive cancers. The trial will evaluate the safety, tolerability, and immunogenicity of INO-3106. This immunotherapy targets human papillomavirus type 6, which causes most aerodigestive cancers. This study is part of Inovio's strategy to broadly expand clinical development of its DNA-based immune therapy products to treat different HPV types and the many diseases they cause. It is a phase I, open label compassionate study enrolling patients with invasive cancer who have exhausted all other treatment options. The study will test Inovio's immunotherapy, INO-3106, alone or in combination with DNA-based IL-12, Inovio's proprietary immune activator, in subjects with HPV-6 associated aerodigestive malignancies. Successful results could open a path to pursuing an FDA orphan designation for aerodigestive cancers.
September 21, 2014
16:02 EDTFBFacebook's Oculus gets closer to consumer release of Rift headset, FT says
Subscribe for More Information
September 19, 2014
11:25 EDTVRX, AGNSenators bring bill requiring companies to settle before inverting
U.S. Senators Sherrod Brown and Dick Durbin announced new legislation requiring corporations to "Pay What You Owe Before You Go" – settling their U.S. tax bill before relocating to a foreign country. "Everyone knows that before you leave a restaurant you have to settle your tab," Brown said. "Corporations shouldn’t get to play by different rules. While it is critical that we reach a long-term solution that reforms our international corporate tax code by implementing a global minimum tax and reducing the statutory tax rate, this bill is an immediate, commonsense measure to ensure businesses settle up before leaving the U.S." Among the deals or possible transactions that involve inversion are Mylan's (MYL) acquisition of Abbott (ABT), Medtronic's (MDT) acquisition of Covidien (COV) and Valeant's (VRX) proposed takeover of Allergan (AGN).
11:24 EDTFBTD Ameritrade:Alibaba premarket orders approaching Facebook levels, Reuters says
Subscribe for More Information
10:59 EDTEBAYSamsung working with PayPal for mobile payments on smartwatch, Gigaom says
Subscribe for More Information
10:53 EDTINO Options with increasing implied volatility: ESI INO VALE AGNC
Subscribe for More Information
September 18, 2014
13:54 EDTFBAd dollars on Facebook outpacing amount of time people spend on site, WSJ says
Subscribe for More Information
13:27 EDTFBFacebook updates story ranking criteria
Subscribe for More Information
12:07 EDTFBStocks with call strike movement; JCP FB
Subscribe for More Information
08:47 EDTEBAYeBay October volatility elevated into Alibaba IPO
eBay September call option implied volatility is at 33, October is at 31, November is at 27, January is at 27; compared to its 26-week average of 26 according to Track Data, suggesting large near term price movement into the expected IPO of Alibaba (BABA) on September 19.
07:06 EDTFBFacebook volatility low into Alibaba IPO
Subscribe for More Information
September 17, 2014
13:57 EDTEBAYiPhone code compromises users, reroutes to fake eBay site, BBC says
Subscribe for More Information
10:04 EDTFBDiscover rumored to be eyed as target by Apple, Bank Innovation says
Subscribe for More Information
09:40 EDTFBFacebook polishing micro-sharing app 'Moments', TechCrunch reports
Facebook is polishing a new app codenamed "Moments" for micro-sharing for a select group of friends, reports TechCrunch. According to multiple sources, including who has seen a live internal version of the app, the design features a grid with a few tiles, each representing a set of close family or friends. The goal is to make selective sharing much faster than the main Facebook app. Reference Link
09:18 EDTEBAYHouse Energy & Commerce Committee to hold a hearing
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use